COPD

Explains how analysis of the heterogeneity of COPD leads to improved, personalized treatment

Presents state of the art knowledge on a range of issues related to COPD heterogeneity

Describes an appropriate tailored treatment strategy for each subgroup of patients

Autorentext
Sang-Do Lee is Professor in Pulmonary and Critical Care Medicine at University of Ulsan College of Medicine. He is the President of Asan Medical Center, Seoul and Director at Clinical Research Center for Chronic Obstructive Airway Diseases.

Inhalt

Overview.- Introduction: Summary.- Definition.- Epidemiology.- Risk Factors.- Pathology/Pathogenesis/Pathophysiology.- Assessment.- Introduction: Summary.- Symptoms: SGRQ, CAT, MRC.- Spirometry.- Images.- Biomarkers.- Comorbidity.- Heterogeneity.- Introduction: Summary.- Phenotypes of COPD.- Genetics.- Images.- ACOS.- Exacerbation.- Pulmonary Hypertension.- Management.- Introduction: Summary.- Prevention.- Pharmacologic.- Non-pharmacologic: LVR, Rehab, Nutritional support.- Management of exacerbation.- Management of Comorbidities.- Personalized Treatment: current practice and evidences from researches.- Prospective.- Cohort: KOLD, ANOLD; Big data, Network medicine.